missing translation for 'onlineSavingsMsg'
Learn More

CD137 Ligand Mouse anti-Human, PE, Clone: C65-485, BD

Mouse Monoclonal Antibody

Brand:  BD Biosciences 559446

Product Code. 15829728

  • ONLINE EXCLUSIVE PRICE
    £313.00
    £300.27 / Each
    Save £12.73
    4% Off

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Reacts with a type II membrane protein known as 4-1BB ligand. This molecule belongs to the TNF superfamily. It has been reported to have costimulatory function on activated T cells. Reports suggest that stimulation of activated T cells via 4-1BB ligand does not require the presence of other costimulatory molecules, including CD28. Some studies have reported human 4-1BB ligand to be expressed preferentially on primary B cells and B-cell lines. C65-485 antibody is able to react with recombinant human 4-1BB ligand (rh4-1BBL) bound to CD137 (4-1BB receptor) expressed on PHA-stimulated PBMC.

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD137 Ligand
Monoclonal
PE
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Affinity Purified
RUO
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
C65-485
4-1BB Ligand
Mouse
100 Tests
Immunology
Human
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.